Covance
Contact Us   |  Client Login  

  • PRODUCTS & SERVICES
    • Antibody Products
      • Antibody Products Store
      • Neuroscience
      • Epitope Tags
      • Structural Proteins & Cell Components
      • Signal Transduction
      • Immunopathology
      • Detection Chemistries & Ancillaries
    • Biopharmaceutical Development
    • Biorepository Services
    • Biotechnology Services
    • Chemistry, Manufacturing and Controls Pharmaceutical Development
    • Clinical Services
      • Bioanalytical
      • Central Laboratory
      • Clinical Development (Phase I-III)
    • Commercialization Services
      • Market Access
    • Discovery & Translational Services
      • Antibody Products
      • Biomarker Center of Excellence
      • BioPathways
      • Computational Biology
      • Discovery
      • Genomics Laboratory
      • Immunology
    • Environmental Sciences
    • Genomics Laboratory
    • Integration in Drug Development
    • Nonclinical Services
      • Antibody Products
      • Bioanalytical Services
      • Discovery
      • Drug Metabolism & Pharmacokinetics
      • Immunology
      • Radiosynthesis
      • Research Models
      • Safety Pharmacology
      • Toxicology
    • Nutritional Chemistry & Food Safety
    • Secure Data Access
    • Strategic Partnering

  • CAREERS
    • Search Jobs
    • College / University
    • Featured Jobs
    • Diversity
    • Benefits
    • 现在就加入科文斯中国!

  • STUDY PARTICIPANTS

  • INVESTORS
    • Investor Information
      • Investor Home
      • Stock Information
      • Board of Directors
      • Corporate Governance Guidelines
      • Analyst Coverage
      • Investor FAQ
      • Presentations & Webcasts
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Press Releases
    • Calendar of Events
    • Request Information

  • NEWS
    • Press Releases
    • Media Relations

  • ABOUT COVANCE
    • Company Overview
    • Industry Overview
    • History of Covance
    • Mission & Vision
    • Executive Leadership
    • Corporate Responsibility Report
    • Awards & Recognitions
    • Global Locations
    • Business Integrity Program
    • Animal Welfare
    • Covance.Asia

  • RESOURCE CENTER
Investors
Investor Information
Investor Home
Stock Information
Board of Directors
Corporate Governance Guidelines
Analyst Coverage
Investor FAQ
Presentations & Webcasts
Financial Information
Calendar of Events
Request Information
Home > Investors > Investor Information
Investor Relations
Investor Information
CVD
Exchange NYSE (US Dollar)
Price $45.57
Change (%)  0.32 (0.71)
Volume 517,567
Data as of Feb 3 2012 4:00PM
Minimum 20 minute delay


Annual Meeting Documents
2010 Annual Report
2011 Notice of Annual Meeting & Proxy Statement


Upcoming & Current Events
There are currently no events scheduled.


Recent Covance News More >>  
DateTitle
02-Feb-2012Covance and BioPontis Alliance Collaborate to Bridge Drug Development Gap Print
25-Jan-2012Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M Print
25-Jan-2012Covance Board Authorizes $300 Million Stock Buyback Print
12-Jan-2012Covance, Inserm Transfert SA, and Inserm Transfert Initiative Enter Four-Year Scientific Agreement Print


Home | Animal Welfare | Privacy Policy | Contact Us | Site Map | Investigators | Covance.Asia
RSS © Copyright 2012 Covance Inc. All rights reserved.